ADD CONDITION

items per page

Topical Anesthetic

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Benzocaine 220 mg/1 g
Other brand names
Dosage form
Gel
Route
Dental
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 1963
Label revision date
April 6, 2012
Active ingredient
Benzocaine 220 mg/1 g
Other brand names
Dosage form
Gel
Route
Dental
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 1963
Label revision date
April 6, 2012
Manufacturer
Patterson Dental Supply Inc
Registration number
part356
NDC root
50227-2114

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Patterson Dental is a topical anesthetic, which means it is applied directly to the skin or mucous membranes to numb the area. It contains 20% benzocaine, a medication that helps relieve pain by blocking nerve signals in the area where it is applied. This product is designed for professional use only and comes in a bubble gum flavor gel, making it more palatable for patients.

If you need a numbing agent for dental procedures or other professional applications, Patterson Dental may be the solution you’re looking for. However, it is important to note that it is available only through prescription.

Uses

You can use this medication as a topical anesthetic, which means it helps numb a specific area of your skin to reduce pain during certain medical procedures. It's important to note that this product is intended for professional use only, so it should be applied by a qualified healthcare provider.

There are no specific concerns regarding teratogenic effects (which refer to substances that can cause birth defects) or nonteratogenic effects (which are effects that do not cause birth defects) associated with this medication. This means that, based on available information, it does not appear to pose risks in these areas.

Dosage and Administration

You should use this medication only in your mouth, as directed by your dentist. It's important to follow their instructions carefully to ensure you get the best results. If you have any questions about how to use it or when to apply it, don't hesitate to ask your dentist for clarification.

What to Avoid

If you have a known allergy to benzocaine or PABA (para-aminobenzoic acid) compounds, it is important that you do not use this medication. Using it in such cases could lead to serious allergic reactions. Always prioritize your safety by avoiding this medication if you have these allergies. If you are unsure about your allergies or have any concerns, please consult with your healthcare provider before using this product.

Side Effects

It's important to be aware of potential side effects when using this medication. If you have a known allergy to benzocaine or PABA compounds, you should avoid using this product, as it may cause serious allergic reactions.

While specific side effects are not detailed here, always monitor your body’s response after taking any medication and consult your healthcare provider if you experience any unusual symptoms. Your safety is a priority, so don't hesitate to reach out with any concerns.

Warnings and Precautions

It's important to keep this medication out of reach of children to prevent accidental ingestion. If you or someone you know has a known allergy to benzocaine or PABA compounds, you should not use this product, as it could trigger a serious allergic reaction.

If you experience any unusual symptoms or reactions after using this medication, stop use immediately and contact your doctor for further guidance. Always prioritize your safety and well-being when using any medication.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health.

Pregnancy Use

When it comes to using this medication during pregnancy, there are no specific guidelines or safety concerns provided. It's important to consult with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. They can help you understand any potential risks and make informed decisions about your treatment options. Always prioritize open communication with your doctor to ensure the best care for you and your baby.

Lactation Use

When it comes to breastfeeding, it's important to be aware that there are no specific guidelines or statements regarding nursing mothers or lactation (the process of producing milk). This means that if you are breastfeeding, you may not find detailed information about how certain medications or treatments could affect you or your baby.

If you have concerns about breastfeeding while taking any medication, it's always a good idea to consult with your healthcare provider. They can provide personalized advice based on your situation and help ensure the safety and well-being of both you and your infant.

Pediatric Use

It's important to keep this medication out of reach of children to ensure their safety. You should not use it on anyone who has known allergies to benzocaine or PABA compounds, as this could lead to serious allergic reactions. Always consult with a healthcare professional if you have any concerns about its use in children or if you notice any unusual symptoms.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider for personalized advice. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment plan is safe and effective for your specific situation. They can help monitor your kidney health and make any necessary adjustments to your medications.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to discuss any concerns regarding your liver health and how it may relate to your treatment. They can help ensure that you receive the safest and most effective care.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking. In this case, there are no specific drug interactions or laboratory test interactions noted, which means that the medication is generally considered safe to use with other drugs and tests. However, every individual is different, and your healthcare provider can help ensure that your treatment plan is safe and effective for you.

Always discuss any changes in your medications or health status with your healthcare provider to avoid any potential issues and to get the best care possible.

Storage and Handling

To ensure the best performance of your product, store it at a controlled room temperature between 59-86°F (15-30°C). This temperature range helps maintain the product's effectiveness and safety.

When handling the product, make sure to do so in a clean environment to avoid contamination. Always follow any specific instructions provided with the product for safe use and disposal. Keeping these guidelines in mind will help you use the product safely and effectively.

Additional Information

No further information is available.

FAQ

What is PATTERSON DENTAL?

PATTERSON DENTAL is a topical anesthetic that contains 20% benzocaine and is available in a bubble gum flavor gel.

Who can use PATTERSON DENTAL?

PATTERSON DENTAL is for professional use only and should be used as directed by a dentist.

What should I know about allergies before using PATTERSON DENTAL?

Do not use PATTERSON DENTAL if you have known allergies to benzocaine or PABA compounds.

What are the storage conditions for PATTERSON DENTAL?

Store PATTERSON DENTAL at a controlled room temperature between 59-86°F (15-30°C).

Is there any information on the use of PATTERSON DENTAL during pregnancy or lactation?

The provided text does not mention any specific information regarding the use of PATTERSON DENTAL during pregnancy or lactation.

What precautions should I take when using PATTERSON DENTAL?

Keep PATTERSON DENTAL out of reach of children and do not use it if you have known allergies to benzocaine or PABA compounds.

Are there any known drug interactions with PATTERSON DENTAL?

No specific drug interactions are mentioned for PATTERSON DENTAL in the provided text.

What is the net content of PATTERSON DENTAL?

PATTERSON DENTAL comes in a net content of 1 fl oz (29.6 mL).

What is the caution regarding dispensing PATTERSON DENTAL?

Federal law prohibits dispensing PATTERSON DENTAL without a prescription.

Packaging Info

Below are the non-prescription pack sizes of Topical Anesthetic (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Topical Anesthetic.
Details

Drug Information (PDF)

This file contains official product information for Topical Anesthetic, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

This topical anesthetic is formulated as a bubble gum flavored gel, containing 20% benzocaine as the active ingredient. It is intended for professional use only and is packaged in a net volume of 1 fluid ounce (29.6 mL).

Uses and Indications

This drug is indicated as a topical anesthetic for professional use only. There are no specific teratogenic or nonteratogenic effects associated with its use.

Dosage and Administration

The product is intended for oral mucosal use only, and it should be administered strictly as directed by a qualified dentist. Healthcare professionals are advised to ensure that patients understand the importance of adhering to the prescribed usage guidelines to achieve optimal therapeutic outcomes.

Contraindications

Use is contraindicated in individuals with known allergies to benzocaine and PABA compounds. Due to the potential for severe allergic reactions, administration in these patients may pose significant health risks.

Warnings and Precautions

It is imperative to keep this product out of reach of children to prevent accidental ingestion or misuse.

Caution is advised in individuals with known hypersensitivity to benzocaine and para-aminobenzoic acid (PABA) compounds. The use of this product in such patients may lead to severe allergic reactions. Healthcare professionals should ensure that patients are screened for these allergies prior to administration.

Side Effects

Patients should be aware that the use of this product is contraindicated in individuals with known allergies to benzocaine and PABA compounds.

In clinical trials and postmarketing experiences, adverse reactions have not been extensively documented; however, the potential for allergic reactions exists, particularly in those with a history of hypersensitivity to the aforementioned compounds. It is essential for healthcare providers to evaluate patients for any prior allergic responses before initiating treatment.

Patients experiencing any signs of an allergic reaction, such as rash, itching, or swelling, should seek immediate medical attention.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions between the drug and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Topical Anesthetic (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Topical Anesthetic.
Details

Pediatric Use

Pediatric patients should be cautioned against the use of this product due to the potential for serious allergic reactions. It is imperative to keep the product out of reach of children. The use of this medication is contraindicated in individuals with known allergies to benzocaine and PABA compounds.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should be aware that the safety of this medication during pregnancy has not been established. There are no available data regarding the potential risks or fetal impacts associated with the use of this medication in pregnant individuals. Healthcare professionals are advised to consider the lack of information when prescribing this medication to women of childbearing potential and to discuss the potential risks and benefits with their patients. It is essential to exercise caution and to monitor any developments closely in pregnant patients who may require treatment.

Lactation

There are no specific statements regarding the use of this medication in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion or misuse. It is essential to inform patients that the product should not be used by individuals with known allergies to benzocaine and PABA compounds, as this may lead to serious allergic reactions. Providers should encourage patients to read the label carefully and discuss any concerns regarding allergies or potential side effects with their healthcare team.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a controlled room temperature, maintaining a range of 59-86°F (15-30°C). Proper storage conditions are crucial to ensure the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Topical Anesthetic, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Topical Anesthetic, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.